Channel: Queen's University Belfast clear
| # | Channel | Title | Views | Likes | Cmts | Score | Sentiment | Duration | Transcript | Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Queen's University Belfast | MRes Translational Medicine | 559 | 7 | 46.5 | 3:42 | We feel translation medicine is like a crucial bridge that enables us to take discovery sands right through from basic sands discovered at the bench, forward into the development of diagnostic tools and potential therapies for patients. I think we're beginning to realise that this whole area of personalized medicine now is a key and no matter what the disease is. For most cases most diseases it's there's no one cure if it's all I think or there's no one treatment for it's all. The key component of the master's programme is actually research so this entails a research project with a dissertation and that actually accounts for two-thirds of the the CASS points or the credits. As well as that then we have the research projects based on which stream you into. We have the Precision Counter Medicine, the diabetes and cardiovascular medicine and the infection inflammation and immunity. We now have drug discovery as a fourth strand which we're quite excited about in this sort of cover all aspects of drug development right through from identifying hits in the labs and to actually making drugs to take forth into clinical trials and patients. The projects are actually submitted by research active group leaders here. All of these are internationally renowned scientists. M.R.S. students are only working alongside PhD students and postdocs in the lab so they'll be working hand in hand with the team that's already here. A part of the project's actually for them to attend the seminars given by international speakers. So we have a weekly seminar from somebody from outside. It comes in a lot of these people are like more leaders in their particular field and the students then are invited to have a tutorial with the speaker and they sit down and have a talk. We have a module which is from concept to commercialisation. That particular module in conjunction with the Queen's Business School takes us a lot about the various aspects of biotech for example, spending companies, entrepreneurship leadership. We want to obviously teach research techniques to the students but on top of that we want to prepare them for all our aspects of medicine, all our aspects of biology. There's sort of applications that will make them competitive in terms of going for a job. We get a lot of students coming from obviously locally from Biomedic Science and the Human Biology Biochemistry courses here in Queens. We also get a lot of international students. We get a lot of clinical academics and we get medical students for example doing intercolletists here. That will give them extra points for their application and their foundation years one and two. And I think the M-rest gins will be exposed to a whole plethora of different applications. Some of the students will be getting hands-on experience in some of the sort of state of the art techniques that we have here. You know the legs of the large scale that aren't a seek and next generation sequence and as well as that we'll be able to align them to actual perhaps patient summals as well because we've dragged access to the Northern bad thing which is actually contained within our center. We have very close ties with industry here as well which makes us very attractive so we actually have within our center CCRCB. We have a couple of biotech firms embedded in the center and they have actually employed some of the graduates from here. I think that the bottom line is can we take this forward to benefit real people? Can we come and see drive improvements in global health across a whole range of areas, cancer, cardiovascular, medicine and infection and immunity? | ↗ |